XBiotech Inc.
XBIT
$2.67
-$0.28-9.49%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 172.68M | 183.12M | 188.53M | 201.04M | 200.02M |
| Total Receivables | 858.00K | 871.00K | 993.00K | 945.00K | 935.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.03M | 1.05M | 1.12M | 1.07M | 760.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 174.57M | 185.03M | 190.64M | 203.06M | 201.72M |
|
|
|||||
| Total Current Assets | 174.57M | 185.03M | 190.64M | 203.06M | 201.72M |
| Net Property, Plant & Equipment | 24.53M | 24.82M | 24.92M | 24.80M | 24.90M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 199.09M | 209.85M | 215.56M | 227.86M | 226.62M |
|
|
|||||
| Total Accounts Payable | 2.22M | 1.51M | 1.70M | 2.61M | 2.52M |
| Total Accrued Expenses | 2.63M | 4.49M | 5.35M | 4.19M | 3.50M |
| Short-term Debt | 10.25M | 10.00M | 10.00M | 10.00M | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | 83.00K | 83.00K | 83.00K |
| Total Other Current Liabilities | -- | -- | 83.00K | 83.00K | 83.00K |
| Total Current Liabilities | 15.11M | 15.99M | 17.14M | 16.88M | 6.10M |
|
|
|||||
| Total Current Liabilities | 15.11M | 15.99M | 17.14M | 16.88M | 6.10M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 10.25M | 10.00M | 10.00M | 10.00M | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.72M | 1.74M | 1.72M | 1.69M | 1.67M |
| Total Liabilities | 16.83M | 17.74M | 18.85M | 18.58M | 7.77M |
|
|
|||||
| Common Stock & APIC | 273.11M | 272.44M | 272.02M | 271.59M | 271.15M |
| Retained Earnings | -90.84M | -80.33M | -75.31M | -62.31M | -52.31M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 182.27M | 192.12M | 196.70M | 209.28M | 218.85M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 182.27M | 192.12M | 196.70M | 209.28M | 218.85M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 182.27M | 192.12M | 196.70M | 209.28M | 218.85M |
|
|
|||||
